Pigment epithelial tears associated with anti-vegf therapy: Incidence, long-term visual outcome, and relationship with pigment epithelial detachment in age-related macular degeneration

Retina

Volumn 34, Issue 6, 2014, Pages 1156-1162

  Doguizi, Sibel ^a,b   Ozdek, Sengul ^a  

^a GAZI UNIVERSITY   (Turkey)

^b Dogubeyazit State Hospital   (Turkey)

Author keywords

Bevacizumab; Macular degeneration; Ranibizumab; Retinal pigment epithelial detachment; Retinal pigment epithelium tears; Vascular endothelial growth factor

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB; VASCULOTROPIN ANTIBODY; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; VASCULOTROPIN A;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; HEIGHT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREVALENCE; RECEIVER OPERATING CHARACTERISTIC; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; RETINA TEAR; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; ANALYSIS OF VARIANCE; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; EPIDEMIOLOGY; MACULAR DEGENERATION; PATHOPHYSIOLOGY; PIGMENT EPITHELIUM; RETINAL DETACHMENT; RETINAL PERFORATIONS; TURKEY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; HUMANS; INCIDENCE; MACULAR DEGENERATION; MALE; RETINAL DETACHMENT; RETINAL PERFORATIONS; RETINAL PIGMENT EPITHELIUM; RETROSPECTIVE STUDIES; TURKEY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84901621766     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000000056     Document Type: Article

References (37)

1. Chang LK, Sarraf D. Tears of the retinal pigment epithelium: An old problem in a new era. Retina 2007;27:523-534. (Pubitemid 46905141
2. Arias L, Caminal JM, Rubio M, et al. Retinal pigment epithelial tears after intravitreal bevacizumab injection for predominantly classic choroidal neovascularization. Eur J Ophthalmol 2007;17:992-995. (Pubitemid 351262915
3. Chan CK, Meyer CH, Gross JG, et al. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Retina 2007;27:541-551. (Pubitemid 46905143
4. Garg S, Brod R, Kim D, et al. Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative agerelated macular degeneration. Clin Experiment Ophthalmol 2008;36:252-256. (Pubitemid 351560274
5. Gelisken F, Ziemssen F, Voelker M, et al. Retinal pigment epithelial tears after single administration of intravitreal bevacizumab for neovascular age-related macular degeneration. Eye (Lond) 2009;23:694-702
6. Mathews JP, Jalil A, Lavin MJ, Stanga PE. Retinal pigment epithelial tear following intravitreal injection of bevacizumab (Avastin): Optical coherence tomography and fluorescein angiographic findings [letter]. Eye (Lond) 2007;21:1004-1005
7. Bakri SJ, Kitzmann AS. Retinal pigment epithelial tear after intravitreal ranibizumab. Am J Ophthalmol 2007;143:505-507. (Pubitemid 46273349
8. Carvounis PE, Kopel AC, Benz MS. Retinal pigment epithelium tears following ranibizumab for exudative age-related macular degeneration. Am J Ophthalmol 2007;143:504-505
9. Chan CK, Lin SG. Retinal pigment epithelial tear after ranibizumab therapy for subfoveal fibrovascular pigment epithelial detachment. Eur J Ophthalmol 2007;17:674-676. (Pubitemid 351175350
10. Kiss C, Michels S, Prager F, et al. Retinal pigment epithelium tears following intravitreal ranibizumab therapy. Acta Ophthalmol Scand 2007;85:902-903. (Pubitemid 350142817
11. Konstantinidis L, Ambresin A, Zografos L, Mantel I. Retinal pigment epithelium tears after intravitreal injection of ranibizumab for predominantly classic neovascular membranes secondary to agerelated macular degeneration. Acta Ophthalmol 2010;88:736-741
12. Lee GK, Lai TY, Chan WM, Lam DS. Retinal pigment epithelial tear following intravitreal ranibizumab injections for neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2007;245:1225-1227. (Pubitemid 47034347
13. Chiang A, Chang LK, Yu F, Sarraf D. Predictors of anti-VEGF-Associated retinal pigment epithelial tear using FA and OCT analysis. Retina 2008;28:1265-1269
14. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Arch Ophthalmol 1993;111:1200-1209
15. Sarraf D, Reddy S, Chiang A, et al. A new grading system for retinal pigment epitelial tears. Retina 2010;30:1039-1045
16. Chan CK, Abraham P, Meyer CH, et al. Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections. Retina 2010;30:203-211
17. Pauleikhoff D, Loffert D, Spital G, et al. Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol 2002;240:533-538
18. Hoskin A, Bird AC, Sehmi K. Tears of detached retinal pigment epithelium. Br J Ophthalmol 1981;65:417-422. (Pubitemid 11046373
19. Singh RP, Sears JE. Retinal pigment epithelial tears after pegaptanib injection for exudative age-related macular degeneration. Am J Ophthalmol 2006;142:160-162. (Pubitemid 43946807
20. Chang LK, Flaxel CJ, Lauer AK, Sarraf D. RPE tears after pegaptanib treatment in age-related macular degeneration. Retina 2007;27:857-863. (Pubitemid 47479380
21. Meyer CH, Mennel S, Schmidt JC, Kroll P. Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degeneration. Br J Ophthalmol 2006;90:1207-1208. (Pubitemid 44351161
22. Nicol F, Ghiglione D, Calabria G. Retinal pigment epithelial tear following intravitreal injection of bevacizumab (Avastin). Eur J Ophthalmol 2006;16:770-773. (Pubitemid 44870767
23. Shah CP, Hsu J, Garg SJ, et al. Retinal pigment epithelial tear after intravitreal bevacizumab injection. Am J Ophthalmol 2006;142:1070-1072
24. Spandau UH, Jonas JB. Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration. Am J Ophthalmol 2006;142:1068-1070. (Pubitemid 44853878
25. Gelisken F, Ziemssen F, Voelker M, Bartz-Schmidt KU. Retinal pigment epithelial tear following intravitreal bevacizumab injection for neovascular age-related macular degeneration. Acta Ophthalmol Scand 2006;84:833-834. (Pubitemid 44688343
26. Kook D, Wolf A, Neubauer AS, et al. Retinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD. Frequency and progress. Ophthalmologe 2008;105:158-164
27. Sarraf D, Chan C, Rahimy E, Abraham P. Prospective evaluation of the incidence and risk factors for the development of rpe tears after high-And low-dose ranibizumab therapy. Retina 2013;33:1551-1557
28. Leitritz M, Gelisken F, Inhoffen W, et al. Can the risk of retinal pigment epithelium tears after bevacizumab treatment be predicted? An optical coherence tomography study. Eye (Lond) 2008;22:1504-1507
29. Green SN, Yarian D. Acute tears of the retinal pigment epithelium. Retina 1983;3:16-20. (Pubitemid 13105657
30. Gass JDM. Pathogenesis of tears of the retinal pigment epithelium. Br J Ophthalmol 1984;68:513-519. (Pubitemid 15135455
31. Chuang EL, Bird AC. Repair after tears of the retinal pigment epithelium. Eye (Lond) 1988;2:106-113. (Pubitemid 18086048
32. Goldstein BG, Pavan PR. Blow-outs in the retinal pigment epithelium. Br J Ophthalmol 1987;71:676-681
33. Spaide RF. Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration. Am J Ophthalmol 2009;147:644-652
34. Wong LJ, Desai RU, Jain A, et al. Surveillance for potential adverse events associated with the use of intravitreal bevacizumab for retinal and choroidal vascular disease. Retina 2008;28: 1151-1158
35. Hartnett ME, Lappas A, Darland D, et al. Retinal pigment epithelium and endothelial cell interaction causes retinal pigment epithelial barrier dysfunction via a soluble VEGF-dependent mechanism. Exp Eye Res 2003;77:593-599. (Pubitemid 37188734
36. Coco RM, Sanabria MR, Hernandez AG, Fernández Muñoz M. Retinal pigment epithelium tears in age-related macular degeneration treated with antiangiogenic drugs: A controlled study with long follow-up. Ophthalmologica 2012;228:78-83
37. Gutfleisch M, Heimes B, Schumacher M, et al. Long-Term visual outcome of pigment epithelial tears in association with anti-VEGF therapy of pigment epithelial detachment in AMD. Eye (Lond) 2011;25:1181-1186.